 Genesis HealthCare Genesis GEN, one of the largest post-acute care providers in the United States, today announced that it received written notification from the New York Stock Exchange the NYSE on April 17, 2020 that it is not in compliance with the NYSE continued listing standard that requires a minimum average closing price of Genesis common stock of 1.00 per share over a consecutive 30 trading-day period the Notice. The Company is, however, in compliance with the NYSE minimum market capitalization threshold of 50 million over a 30 trading-day period. The Notice also has no immediate impact on the listing of Genesis common stock, which will continue to be listed and traded on the NYSE during the applicable cure period under the symbol GEN, subject to Genesis compliance with other continued listing requirements set forth in the NYSE Listed Company Manual, but will have an added designation of .BC to indicate the status of the common stock as below compliance with the NYSE continued listing standards. 